American Capital Advisory’s Moderna MRNA Stock Holding History

American Capital Advisory’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$841	Buy	12 +4	+50%	+$207	﹤0.01%	839
2026 Q1	$407	Buy	+8	New	+$373	﹤0.01%	901
2025 Q3	–	Sell	-3	Closed	-$83	–	1038
2025 Q2	$83	Buy	3 +1	+50%	+$26	﹤0.01%	849
2025 Q1	$57	Buy	+2	New	+$71	﹤0.01%	791

Other funds holding MRNA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BPC

Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return

Merck & Co Kenilworth, New Jersey $526M AUM 175.27% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

LIM

Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

American Capital Advisory's MRNA Position: Q2 2026 in Review

American Capital Advisory increased its Moderna (MRNA) stake by 50% in Q2 2026, buying an estimated $207 and bringing the position to 12 shares worth $841. The position accounts for ﹤0.01% of the portfolio, ranked #839.

American Capital Advisory first reported a position in MRNA in Q1 2025 and has held it in 4 quarters since. 399 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

American Capital Advisory held 12 shares of Moderna worth $841 as of Q2 2026.
American Capital Advisory bought 4 Moderna shares in Q2 2026, an estimated $207.
Moderna made up ﹤0.01% of American Capital Advisory's portfolio in Q2 2026, its #839 holding.
American Capital Advisory first reported a position in Moderna in Q1 2025 and has held it in 4 quarters since.
399 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on American Capital Advisory's 13F filing for Q2 2026, filed 28 Jul 2026.